Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta‐Analyses

Documenti analoghi

• Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab‐Paclitaxel in Pancreatic Cancer: A Systematic Review
  di: Hanye Sohrabi, et al.
  Pubblicazione: (2026)
• Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
  di: Yuta Yamanaka, et al.
  Pubblicazione: (2024)
• Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors
  di: Wenke Li, et al.
  Pubblicazione: (2025)
• Exploration of the Optimal Treatment Modality for Vitreoretinal Lymphoma: A PRISMA Compliant Meta‐Analysis and Systematic Review
  di: Jing Gao, et al.
  Pubblicazione: (2025)
• Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis
  di: Malek Shatila, et al.
  Pubblicazione: (2025)